Ajibaye Olusola, Osuntoki Akinniyi A, Ebuehi Albert Ot, Iwalokun Bamidele A, Balogun Emmanuel O, Egbuna Kathleen N
Biochemistry and Nutrition Division, Nigerian Institute of Medical Research, Lagos, Nigeria.
Department of Biochemistry, College of Medicine, University of Lagos, Lagos, Nigeria.
Adv Biomed Res. 2017 Nov 10;6:142. doi: 10.4103/2277-9175.192631. eCollection 2017.
Polymorphisms in merozoite surface protein-2 (-2) and associated parasite genetic diversity which varies between malaria-endemic regions remain a limitation in malaria vaccine development. Pro-inflammatory cytokines are important in immunity against malaria, understanding the influence of genetic diversity on cytokine response is important for effective vaccine design.
isolates obtained from 300 Nigerians with uncomplicated falciparum malaria at Ijede General Hospital, Ijede (IJE), General Hospital Ajeromi, Ajeromi (AJE) and Saint Kizito Mission Hospital, Lekki, were genotyped by nested polymerase chain reaction of -2 block 3 while ELISA was used to determine the pro-inflammatory cytokine response to describe the genetic diversity of .
Eighteen alleles were observed for -2 loci. Of the 195 isolates, 61 (31.0%) had only FC27-type alleles, 38 (19.7%) had only 3D7-type alleles, and 49.3% had multiple parasite lines with both alleles. Band sizes were 275-625 bp for FC27 and 150-425 bp for 3D7. Four alleles were observed from LEK, 2 (375-425 bp) and 2 (275-325 bp) of FC27-and 3D7-types, respectively; 12 alleles from AJE, 9 (275-625 bp) and 3 (325-425 bp) of FC27-types and 3D7-types, respectively; while IJE had a total of 12 alleles, 9 (275-625 bp) and 3 (325-425 bp) of FC27-types and 3D7-types, respectively. Mean multiplicity of infection (MOI) was 1.54. Heterozygosity () ranged from 0.77 to 0.87 and was highest for IJE (0.87). Cytokine response was higher among <5 years and was significantly associated with MOI ( > 0.05) but with neither parasite density nor infection type.
genetic diversity is extensive in Nigeria, protection via pro-inflammatory cytokines have little or no interplay with infection multiplicity.
裂殖子表面蛋白-2(MSP-2)的多态性以及不同疟疾流行地区相关寄生虫的遗传多样性差异仍是疟疾疫苗研发的一个限制因素。促炎细胞因子在抗疟疾免疫中很重要,了解遗传多样性对细胞因子反应的影响对于有效的疫苗设计至关重要。
从伊杰德综合医院(Ijede,IJE)、阿杰罗米综合医院(Ajeromi,AJE)和莱基圣基齐托传教医院的300名患单纯性恶性疟的尼日利亚患者中分离出的菌株,通过对MSP-2第3区进行巢式聚合酶链反应进行基因分型,同时使用酶联免疫吸附测定法(ELISA)来确定促炎细胞因子反应,以描述MSP-2的遗传多样性。
观察到MSP-2位点有18个等位基因。在195个分离株中,61个(31.0%)仅有FC27型等位基因,38个(19.7%)仅有3D7型等位基因,49.3%有同时携带两种等位基因的多个寄生虫株。FC27的条带大小为275 - 625 bp,3D7的条带大小为150 - 425 bp。从莱基观察到4个等位基因,分别为2个FC27型(375 - 425 bp)和2个3D7型(275 - 325 bp);从阿杰罗米观察到12个等位基因,分别为9个FC27型(275 - 625 bp)和3个3D7型(325 - 425 bp);而伊杰德共有12个等位基因,分别为9个FC27型(275 - 625 bp)和3个3D7型(325 - 425 bp)。平均感染复数(MOI)为1.54。杂合度(He)范围为0.77至0.87,伊杰德的杂合度最高(0.87)。5岁以下儿童的细胞因子反应较高,且与MOI显著相关(P > 0.05),但与寄生虫密度和感染类型均无关。
尼日利亚的MSP-2遗传多样性广泛,促炎细胞因子介导的保护作用与感染复数之间几乎没有相互作用。